Brief: Inventiva End-March Cash Position At EUR 80.5 Mln

Inventiva SA

17/05/2022 07:04

May 17 (Reuters) - Inventiva  IVAA.PA :
    * REPORTED ON MONDAY CASH POSITION AT EUR 80.5 MLN AS OF
MARCH 31
VS EUR 95.4 MLN AS OF DECEMBER
    * GROUP DID NOT GENERATE ANY REVENUE IN Q1 2022
    * RECRUITMENT FOR PHASE III TRIAL NATIV3 OF LANIFIBRANOR IN
NASH
CONTINUES WITH FULL REGULATORY APPROVAL OBTAINED IN 23 OUT OF 24
COUNTRIES
    * HOWEVER, COVID-19 PANDEMIC AND CONFLICT IN UKRAINE AND
RELATED
SANCTIONS AGAINST RUSSIA HAVE IMPACTED RECRUITMENT FOR NATIV3
    * RECRUITMENT HAS BEEN PUT ON HOLD IN UKRAINE AND THE
DECISION HAS
BEEN TAKEN TO REMOVE ALL OF INVENTIVA’S PLANNED SITES IN RUSSIA
FROM THE TRIAL
    * NOW EXPECTS TO FINALISE PART 1 RECRUITMENT FOR THE NATIV3
STUDY
IN THE FIRST HALF OF 2023 VERSUS THE SECOND HALF OF 2022 AS
PREVIOUSLY ANNOUNCED
    * GROUP REMAINS CONFIDENT IN ITS RECRUITMENT STRATEGY AND
HAS
BEGUN IMPLEMENTING MEASURES TO COMPENSATE FOR THE LOSS OF SITES
IN UKRAINE AND RUSSIA
    * TIMING FOR DATA READOUTS FOR PHASE II TRIAL OF
LANIFIBRANOR IN
NAFLD PATIENTS WITH TYPE 2 DIABETES AND FOR PHASE II LEGEND
TRIAL COMBINING LANIFIBRANOR WITH SGLT2 INHIBITOR EMPAGLIFLOZINE
REMAIN UNCHANGED


        
 Source text for Eikon:  urn:newsml:reuters.com:*:nGNX7GPZsl
 Further company coverage:  IVAA.PA  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))